Albemarle, a leading global provider of custom manufacturing services, announced it will partner with PharmaCore to provide manufacturing capabilities for customers with projects that require high volume capacity.
This alliance allows a seamless technology transfer from PharmaCore to Albemarle, offering PharmaCore customers long term, higher volume capacity for their pharmaceutical projects. Albemarle's custom manufacturing capabilities include a network of manufacturing assets in South Haven, Mich., Tyrone, Pa. and Orangeburg, S.C., providing Active Pharmaceutical Ingredients (APIs) and advanced pharmaceutical intermediate production in a broad range of scale and chemistries.
Track · email · face · Twitter · digg · COMMENTS
by Michael Oliveto
Advertisement